Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Amcinonide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 8/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 8/20 | 0.85 |
| ▸ | LMNA | P02545 | 5/20 | 0.85 |
| ▸ | PGR | P06401 | 5/20 | 0.85 |
| ▸ | CNR1 | P21554 | 2/20 | 0.85 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.85 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.85 |
| ▸ | USP2 | O75604 | 1/20 | 0.85 |
| ▸ | MAPT | P10636 | 1/20 | 0.85 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.72 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | AR | P10275 | 2/20 | 0.68 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amcinonide SCHEMBL13026154 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL5488922 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL21051752 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL4720 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL1649481 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL12396698 | 0.92 | HIF1A (1.00) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Amcinonide SCHEMBL13723413 | 0.91 | HIF1A (0.70) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Fluocinonide SCHEMBL28122375 | 0.89 | HIF1A (0.75) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Fluocinonide SCHEMBL3475945 | 0.89 | HIF1A (0.75) | CYP3A4HIF1ANR3C1LMNAPGR | |
| Betamethasone Acetate SCHEMBL3681474 | 0.88 | HIF1A (0.94) | CYP3A4HIF1ANR3C1LMNAPGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968368-A2 | CRANIAL DELIVERY OF PHARMACEUTICALS | Glia LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014152385-A2 | CRANIAL DELIVERY OF PHARMACEUTICALS | GLIA, LLC (US) | 2014-09-25 | — | — | WO | disclosed |